Moderna Stock Outpaces Broader Markets as Investors Eye Upcoming November Earnings

Moderna shares recently finished a trading session higher than the broader market, closing at $245.81 to mark a 1.54% increase from the previous day’s close. The biotechnology company’s performance outpaced the S&P 500, which recorded a gain of 0.58% for the day. At the same time, the Dow Jones Industrial Average rose by 0.69%, while … The post Moderna Stock Outpaces Broader Markets as Investors Eye Upcoming November Earnings appeared first on MISRYOUM.

This page displays only the headline and feed summary. The full article remains on the original publisher's website.